tci Medicare Compliance & Reimbursement - 2005 Issue 36

Hospitals: Don't Forget About Pending OPPS Changes

Pass-through payments possible for certain codes.The bulk of the changes to hospital outpatient prospective payment system billing procedures and payment policies will affect facility claims for drugs and biologicals.Effective Oct. 1, 2005, the Centers for Medicare and Medicaid Services will grant "pass-through" status to C9225 (Injection, fluocinolone acetonide intravitreal implant, per 0.59 mg) and C9226 (Injection, ziconotide for intrathecal infusion, per 5 mcg), the agency announced in a Sept. 2 Medlearn Matters article. Other changes under the October OPPS update include:• The pass-through status effective date for J8501 (Aprepitant, oral, 5 mg) is April 4...

To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.

Thank you for choosing Find-A-Code, please Sign In to remove ads.